logo-loader
viewBiomerica, Inc.

Biomerica seeing their colorectal cancer screening test as a game changer

Biomerica (NASDAQ: BMRA) CEO Zack Irani-Cohen sat down with Proactive's Steve Darling at the 12th annual LD Micro Conference in Bel Air, California. The Irvine, California-based company develops, manufactures, and markets medical diagnostic products for the early detection and monitoring of chronic diseases and medical conditions. Biomerica also has developed its patented InFoods product to treat irritable bowel syndrome and other gastrointestinal diseases.

Quick facts: Biomerica, Inc.

Price: 3 USD

NASDAQ:BMRA
Market: NASDAQ
Market Cap: $29.67 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Buds & Duds: Cannabis stocks finish week in the red; Canaccord initiates...

The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada, was down 2.6% higher at 117.4 points. Elsewhere, the OTCQX Cannabis index fell 1.8% to 480.1 points. Buds today were Pharmacielo Ltd (CVE:PCLO), The Valens Company (CVE:VLNS) (OTCMKTS:VLNCF)....

2 days, 9 hours ago

2 min read